Latest Anz News

Orthocell has completed its first Remplir™ surgical case in Hong Kong, marking a pivotal step in its Asian commercialisation strategy. The launch at the Hong Kong Orthopaedic Association Congress and partnership with MontsMed set the stage for broader regional growth.

ANZ Group Holdings Limited has announced a 1.5% discount on shares acquired through its Dividend Reinvestment and Bonus Option Plans for the upcoming 2025 final dividend, signaling a subtle shift in shareholder incentives.

RMA Global Limited kicked off FY26 with a robust 21% increase in recurring revenue, driven by the rollout of Curated Social and a strategic pivot to target US brokerages exclusively. The company’s new Social Studio platform is gaining traction across the US, Australia, and New Zealand.

PainChek Ltd has achieved a pivotal FDA De Novo clearance for its AI-driven Adult pain assessment app, unlocking the US market and driving its annual recurring revenue to $5.6 million. The company also launched its Infant app, targeting a vast global market of pre-verbal children.

PainChek has secured FDA De Novo clearance for its Adult App, opening immediate access to a $175 million AUD US long-term care market and advancing its Infant App commercialization targeting a $15 billion AUD global opportunity.

Nuchev Limited reported a robust 30% increase in group revenue to $6.5 million in Q1 FY26, driven by strong sales across ANZ, China, and a new foothold in Vietnam. The company’s strategic acquisitions and product launches underpin its expanding market presence and diversification.

Jumbo Interactive has acquired Dream Giveaway, a leading US digital prize draw business, marking its strategic entry into the lucrative American B2C prize market. The A$55.4 million deal leverages Dream Giveaway’s established brand and loyal customer base to accelerate Jumbo’s international growth.

Jumbo Interactive has completed its strategic entry into the US prize draw market by acquiring Dream Giveaway for A$55.4 million, aiming to leverage its digital expertise to fuel growth in a large, underpenetrated market.

Nick Scali Limited reported a robust $62 million underlying profit for FY25, completed its UK acquisition equity raise, and announced key leadership changes as it eyes accelerated growth in FY26.

Orthocell has appointed MontsMed as the exclusive distributor for its nerve repair product Remplir™ in Hong Kong, marking a significant step in its Asian commercialisation strategy. This move opens access to the vast Guangdong-Hong Kong-Macao Greater Bay Area, complementing existing operations in Singapore and planned expansion in Thailand.

Carlton Investments reported a slight rise in net profit and an 8.7% increase in dividends for FY2025, while its investment portfolio grew nearly 60% over five years despite recent market fluctuations.

Credit Corp Group has reaffirmed its FY26 guidance, highlighting robust earnings growth driven by operational improvements across its US debt buying and Australian/New Zealand lending segments.